The 2017 ESMO Annual Congress, taking place September 8 to 12 in Madrid, Spain, will feature several late-breaking abstracts that are poised to change the future of treatment for patients with lung cancer, pending their results, including the phase III PACIFIC and FLAURA studies. ...
ESMO Open Open access 11.7CiteScore 7.1Impact Factor Articles & Issues About Publish Submit your articleGuide for authors Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June – 3 July 2018 Pages A1-A463 (30 June–3 July ...
Miller R E,Ledermann J A.The European Society for Medical Oncology (ESMO) Congress 2016:Highlights and summary of selected abstracts in gynecologic cancers[J].Gynecologic oncology,2017,144(1):8-10.The European Society for Medical Oncology (ESMO)Congress 2016:Highlights and summary of selected ...
Untreated breast cancer cells withHER2mutations, top image. Cells shrink after treatment with neratinib, bottom. “We find many mutations that are only present in 1%, 2%, or 3% of cancers, which means that if we try to design therapy that counteracts the effects of these mutations with new ...
Following the 2019 ESMO Congress, experts across various fields highlighted some next steps and how these treatment options will improve the treatment landscape for patients with ovarian, lung, breast, GI, or GU cancers. Overall, the abstracts presented